Citation Impact

Citing Papers

Global phosphorylation analysis of β-arrestin–mediated signaling downstream of a seven transmembrane receptor (7TMR)
2010 StandoutNobel
Functional specialization of β-arrestin interactions revealed by proteomic analysis
2007 StandoutNobel
Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring
2013 Standout
Mutant G-protein-coupled receptors as a cause of human diseases
2004
Pathogenesis of Osteoarthritis
1970
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis
2011
β-Arrestin-mediated Signaling Regulates Protein Synthesis
2008 StandoutNobel
Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity
2017 StandoutNobel
The contribution of PARs to inflammation and immunity to fungi
2008
Contribution of platelets to tumour metastasis
2011 Standout
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage
2007
β-Arrestin-dependent Regulation of the Cofilin Pathway Downstream of Protease-activated Receptor-2
2007
High-resolution crystal structure of human protease-activated receptor 1
2012 StandoutNatureNobel
The role of intracellular Ca2+ in the regulation of proteinase‐activated receptor‐2 mediated nuclear factor kappa B signalling in keratinocytes
2005
Analysis of Proteinase-activated Receptor 2 and TLR4 Signal Transduction
2008
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
2007 Standout
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Ubiquitination of β-Arrestin Links Seven-transmembrane Receptor Endocytosis and ERK Activation
2007 StandoutNobel
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
2005
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
1997 StandoutNature
IL-6 as a keystone cytokine in health and disease
2015 Standout
Irritable bowel syndrome
2016 Standout
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Tissue factor in cancer progression and angiogenesis
2010
The Rise and Fall of the Chemoattractant Receptor GPR33
2005 StandoutNobel
Platelet Activation and Atherothrombosis
2007 Standout
Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both β-Arrestin-1 and -2
2004 StandoutNobel
The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets
2012 StandoutNobel
2-Furoyl-LIGRLO-amide: A Potent and Selective Proteinase-Activated Receptor 2 Agonist
2004
The development of allergic inflammation
2008 StandoutNature
The Collagen Family
2010 Standout
A Polyclonal Antibody to the Prepore Loop of Transient Receptor Potential Vanilloid Type 1 Blocks Channel Activation
2006
Mast Cell Proteases
2007
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
2011 StandoutNobel
Role for protease activity in visceral pain in irritable bowel syndrome
2007
Sensors of the innate immune system: their mode of action
2009 StandoutNobel
Prophylactic inhibition of neutrophil elastase prevents the development of chronic neuropathic pain in osteoarthritic mice
2017
Targeting proteinase-activated receptors: therapeutic potential and challenges
2012
Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more
2007
Protease Activated Receptor-2 Mediates Activated Protein C–Induced Cutaneous Wound Healing via Inhibition of p38
2011
Protease-activated receptors: novel PARtners in innate immunity
2007
Mite and Cockroach Allergens Activate Protease-Activated Receptor 2 and Delay Epidermal Permeability Barrier Recovery
2008
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
Cartilage in normal and osteoarthritis conditions
2008
Structure and signalling in the IL-17 receptor family
2009 Standout
A 20-year retrospective review of global aquaculture
2021 StandoutNature
Spatial and temporal dynamics of the endothelium
2005
Immunity to fungal infections
2011 Standout
The acute respiratory distress syndrome
2012 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Diet‐induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism
2013
β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
2009 StandoutNobel
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
2004 StandoutNobel
Minocycline: far beyond an antibiotic
2013 Standout
Important antinutrients in plant feedstuffs for aquaculture: an update on recent findings regarding responses in salmonids
2010
Stop That Cell! β-Arrestin-Dependent Chemotaxis: A Tale of Localized Actin Assembly and Receptor Desensitization
2006
Thrombin and Phenotypic Modulation of the Endothelium
2003
Protease-Activated Receptors: Contribution to Physiology and Disease
2004
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response
2004
Physiology of Microglia
2011 Standout

Works of Lynette Dunning being referenced

Proteinase-activated receptor 2 modulates OA-related pain, cartilage and bone pathology
2015
Expression and proinflammatory role of proteinase‐activated receptor 2 in rheumatoid synovium: Ex vivo studies using a novel proteinase‐activated receptor 2 antagonist
2007
Essential role for proteinase-activated receptor-2 in arthritis
2003
Therapeutic Promise of Proteinase-Activated Receptor-2 Antagonism in Joint Inflammation
2006
Essential role for proteinase-activated receptor-2 in arthritis
2003
Rankless by CCL
2026